Foremost Health Care Services

Foremost Health Care Services

Motivated by the vision and mission of Dr. M. Mark Wexler to enhance quality of life for those suffering from various pain disorders, we redefine pain and migraine management through the transformative realm of medical hypnotherapy. With over 30 years of pain treatment experience, our expertise is centered around guiding individuals toward relief, all without the undue reliance on medications.


Our journey has been marked by unwavering dedication to alleviating pain and restoring lives. A significant chapter of Dr. M. Mark Wexler's experience includes serving as an Army neuropsychologist during the challenging period of the Persian Gulf War, from 1990 to 1994. This unique background infuses the practice with resilience, compassion, and an unwavering commitment to your well-being.


At Dr. Stop Pain, we stand at the forefront of innovation in pain management. Our approach revolves around harnessing the power of medical hypnotherapy, an AMA-approved technique that has proven its efficacy for over 100 years. Dr. Wexler has meticulously crafted hypnotherapy sessions tailored for chronic pain and migraine relief.


What truly sets our practice apart is a combination of factors that converge to create an unparalleled solution for pain relief. Firstly, the excellent training and expertise as a seasoned health professional forms the bedrock of our approach. Secondly, our creation of American Medical Association approved products speaks to the credibility and safety of the treatments we offer. Thirdly, the effectiveness of our products is clinically proven, a testament to their transformative impact. Finally, in a landscape where few have ventured, we take pride in being pioneers in making this unique treatment approach available in the comfort of your own home.

 

Embark on this journey of renewal with us. Explore our Migraine Relief Program and Chronic Pain Relief Program, meticulously designed to guide you towards a life unburdened by pain.


©Dr. Stop Pain 2024